Market Research Logo

Iran Pharmaceuticals and Healthcare Report Q1 2016

Iran Pharmaceuticals and Healthcare Report Q1 2016

Iran Pharmaceuticals and Healthcare Report Q1 2016

BMI View: In light of easing economic sanctions, international drugmakers - both R&D-based and genericdrug firms - will seek to gain a local presence in Iran's pharmaceutical market. Import restrictions meansupply opportunities will be very problematic for generic drugmakers without a local presence. The supplyof patented drugs will be easier for multinationals, although a local presence will be the ideal scenario formost drugmakers.Headline Expenditure Projections

Pharmaceuticals: IRR60.70tn (USD2.35bn) in 2014 to IRR69.55trn (USD1.93bn) in 2015; +14.6% inlocal currency terms and -17.8% in US dollar terms. Forecast unchanged from previous quarter.

Healthcare: IRR711.91trn (USD22.39bn) in 2014 to IRR819.73trn (USD22.77bn) in 2015; +15.1% inlocal currency terms and +1.7% in US dollar terms. Forecast slightly upgraded from previous quarter.


BMI Industry View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Iran 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Iran 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Iran 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Iran 2011-2019)
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Market Forecast
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Iran 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Iran 2013-2019)
Key Risks To BMI's Forecast Scenario
Industry Risk/Reward Index
Middle East and Africa Risk/Reward Index - Q1 2016
Iran Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Regime
Counterfeit Medicines
Pricing And Reimbursement
Market Overview
Healthcare Sector
Table: Healthcare Resources (Iran 2009-2014)
Table: Healthcare Personnel (Iran 2009-2014)
Table: Healthcare Activity (Iran 2009-2014)
Healthcare Insurance
International Healthcare Collaboration
Traditional Herbal Remedies
Research & Development
Biotechnology
Clinical Trials
Epidemiology
Competitive Landscape
Pharmaceutical Sector
Generic Drugmakers
Table: Leading Drug Manufacturers, Iranian Year To March 20, 2009
Pharmaceutical Distribution
Table: Leading Distributors, Iranian Year To March 20 2008
Pharmaceutical Retail Sector
Table: Tehran Stock Exchange - Listed Pharmaceutical Companies As Of November 2015
Table: Multinational Company Activity
Company Profile
Caspian Tamin Pharmaceutical Company
Darou Pakhsh
Exir Pharmaceuticals
Pars Darou
Zahravi Pharmaceutical Company
Demographic Forecast
Table: Population Headline Indicators (Iran 1990-2025)
Table: Key Population Ratios (Iran 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Iran 1990-2025)
Table: Population By Age Group (Iran 1990-2025)
Table: Population By Age Group % (Iran 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report